Bank of America
AXSM icon

Bank of America’s Axsome Therapeutics AXSM Stock Holding History

Bank of America’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-146,000
Closed -$12.4M – 8309
2024
Q4 		$12.4M Buy
146,000
+144,000
+7,200% +$13.2M ﹤0.01% 2741
2024
Q3 		$180K Hold
2,000
– – ﹤0.01% 6062
2024
Q2 		$161K Buy
2,000
+500
+33% +$37K ﹤0.01% 6004
2024
Q1 		$120K Buy
+1,500
New +$126K ﹤0.01% 6157

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of America's AXSM Position: Q1 2026 in Review

Bank of America reduced its Axsome Therapeutics (AXSM) stake by 3.2% in Q1 2026, selling an estimated $3.44M and leaving 598,091 shares worth $101M. The position accounts for 0.01% of the portfolio, ranked #1111.

Bank of America first reported a position in AXSM in Q2 2016 and has held it in 35 quarters since. The position peaked at $113M in Q4 2025. 409 funds tracked by Wall St. Rank hold AXSM as of Q1 2026.

  • Bank of America held 598,091 shares of Axsome Therapeutics worth $101M as of Q1 2026.
  • Bank of America sold 19,942 Axsome Therapeutics shares in Q1 2026, an estimated $3.44M.
  • Axsome Therapeutics made up 0.01% of Bank of America's portfolio in Q1 2026, its #1111 holding.
  • Bank of America first reported a position in Axsome Therapeutics in Q2 2016 and has held it in 35 quarters since.
  • Bank of America's Axsome Therapeutics position peaked at $113M in Q4 2025.
  • 409 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.